Summit Therapeutics (NASDAQ:SMMT) has outperformed the market over the past 5 years by 73.1% on an annualized basis producing an average annual return of 86.39%. Currently, Summit Therapeutics has a market capitalization of $23.67 billion.
Buying $100 In SMMT: If an investor had bought $100 of SMMT stock 5 years ago, it would be worth $2,218.62 today based on a price of $32.21 for SMMT at the time of writing.
Summit Therapeutics's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
